Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Pro Dex Inc

NASDAQ: PDEX · Industrial Applications and Services · 5 alerts · CIK 788920

Share price
$64.48Close, Nov 16
Market cap
$206M
Shares outstanding
3.2MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Pro Dex Inc filings on SEC EDGAR ↗

4:09 PM ET 8-K
Loan & Debt

Pro Dex $8.51M Debt Financing with UMB Bank, N.A.

Pro-Dex, Inc. entered into an amendment to its credit agreement with UMB Bank to consolidate the outstanding principal balances of two term notes into a single $8.51 million Term Note D. The amendment extends the maturity date to November 1, 2031, sets a fixed interest rate of 6.67% per annum, and extends the maturity of its revolving note to December 31, 2028.

Value
$8.51M
Counterparty
UMB Bank, N.A.
Term
through Nov 2031
4:08 PM ET 8-K
Capacity Expansion

Pro Dex Capacity Expansion

Pro-Dex subsidiary Advanced Precision Machining (APM) entered into a new lease for a 5,800 square foot industrial unit in Costa Mesa, California, and renewed existing leases for its current manufacturing and warehouse space through September 2030. The new facility more than doubles APM's existing 2,500 square foot footprint, supporting expanded manufacturing and office operations.

Counterparty
Salter Family Trust
Term
through Sept 2030
4:05 PM ET 8-K
Financial Results

Pro Dex Financial Results

Pro-Dex, Inc. reported its fiscal 2027 first quarter results, with net sales increasing 11% to $20.6 million driven by medical device revenue growth. Net income decreased to $3.0 million from $4.7 million in the prior year, primarily due to a significant decrease in unrealized gains on marketable equity investments compared to the year-ago period.

Term
Q1 2027

“We are pleased with our first quarter results and continued top line revenue growth.”

Richard L. (“Rick”) Van Kirk, the Company’s President and Chief Executive Officer

“We are also pleased to be working with the Monogram and Zimmer Biomet teams and expect to ship validation units later this fiscal year.”

Richard L. (“Rick”) Van Kirk, the Company’s President and Chief Executive Officer
4:02 PM ET 10-Q
Financial Results

Pro Dex Q1 2026 Results: Net Income $3.05M, Down 34.9% YoY

For the three months ended September 30, 2026, Pro-Dex reported net sales of $20.6 million, an 11% increase over the prior year, though net income decreased to $3.0 million from $4.7 million due to a significantly smaller unrealized gain on investments. The company maintained a strong balance sheet with $11.8 million in cash and expanded its operations into precision machined parts for the aerospace and defense industries.

Key figure
Net income $3.05M · -34.9% YoY

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.